Investors

  • 2021-10-28
    NEXT DAY DISCLOSURE RETURN
  • 2021-10-27
    NEXT DAY DISCLOSURE RETURN
  • 2021-10-26
    NEXT DAY DISCLOSURE RETURN
  • 2021-10-25
    NEXT DAY DISCLOSURE RETURN
  • 2021-10-22
    NEXT DAY DISCLOSURE RETURN
  • 2021-10-06
    MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED SEPTEMBER 30
  • 2021-10-04
    NEXT DAY DISCLOSURE RETURN
  • 2021-09-30
    SUPPLEMENTAL ANNOUNCEMENT UPDATE IN RELATION TO DISCLOSEABLE TRANSACTION
  • 2021-09-29
    VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON THE SUBMISSION OF NEW DRUG APPLICATION IN HONG KONG FOR XERAVATM FOR THE TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS
  • 2021-09-24
    VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON THE APPROVAL OF INVESTIGATIONAL NEW DRUG APPLICATION BY CHINA NMPA FOR SPR206
 Copyright Everest Medicines 2020  云顶药业(苏州)有限公司 苏ICP备20038571号 |  Terms of Use |  Privacy Policy |  Disclaimers

沪公网安备 31010602006477号